• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病与心力衰竭:一项全面的生物信息学和孟德尔随机化分析

Non-alcoholic fatty liver disease and heart failure: A comprehensive bioinformatics and Mendelian randomization analysis.

作者信息

Zhang Yayun, Feng Lu, Guan Xin, Zhu Zixiong, He Yubin, Li Xuewen

机构信息

Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.

Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.

出版信息

ESC Heart Fail. 2024 Dec;11(6):4185-4200. doi: 10.1002/ehf2.15019. Epub 2024 Aug 14.

DOI:10.1002/ehf2.15019
PMID:39143741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11631243/
Abstract

AIMS

Heart failure (HF) and non-alcoholic fatty liver disease (NAFLD) are significant global health issues with a complex interrelationship. This study investigates their shared biomarkers and causal relationships using bioinformatics and Mendelian randomization (MR) approaches.

METHODS

We analysed NAFLD and HF datasets from the Gene Expression Omnibus (GEO). The GSE126848 dataset included 57 liver biopsy samples [14 healthy individuals, 12 obese subjects, 15 NAFL patients and 16 non-alcoholic steatohepatitis (NASH) patients]. The GSE24807 dataset comprised 12 NASH samples and 5 healthy controls. The GSE57338 dataset included 313 cardiac muscle samples [177 HF patients (95 ischaemic heart disease patients and 82 idiopathic dilated cardiomyopathy patients) and 136 healthy controls]. The GSE84796 dataset consisted of 10 end-stage HF patients and 7 healthy hearts procured from organ donors. We identified differentially expressed genes (DEGs) and constructed a protein-protein interaction (PPI) network. Functional pathways were elucidated through enrichment analyses using Gene Ontology (GO), the Kyoto Encyclopedia of Genes and Genomes (KEGG) and GeneMANIA annotation. Single nucleotide polymorphism (SNP) data for HF and NAFLD were sourced from genome-wide association studies (GWAS). The HF dataset included 486 160 samples (14 262 experimental and 471 898 control), and the NAFLD dataset comprised 377 988 samples (4761 experimental and 373 227 control). MR analysis investigates the causal interrelations.

RESULTS

Our analysis revealed 4032 DEGs from GSE126848 and 286 DEGs from GSE57338. The top 10 hub genes (CD163, VSIG4, CXCL10, FCER1G, FPR1, C1QB, CCR1, C1orf162, MRC1 and CD38) were significantly enriched in immune response, calcium ion concentration regulation and positive regulation of monocyte chemotaxis. CIBERSORT analysis indicated associations between these hub genes and natural killer (NK) cells and macrophages. Transcription factor (TF) target prediction for CD38, CXCL10 and CCR1 highlighted related TFs. A two-sample MR analysis confirmed a bidirectional causal relationship between NAFLD and HF. The main method [inverse variance weighted (IVW)] demonstrated a significant positive causal relationship between NAFLD and HF [P = 0.037; odds ratio (OR) = 1.024; 95% confidence interval (CI): 1.001 to 1.048]. Similarly, HF was associated with an increase in the risk of NAFLD (P < 0.001; OR = 1.117; 95% CI: 1.053 to 1.185).

CONCLUSIONS

Our findings reveal novel molecular signatures common to NAFLD and HF and confirm their bidirectional causality, highlighting the potential for targeted therapeutic interventions and prompting further investigation into their intricate relationship.

摘要

目的

心力衰竭(HF)和非酒精性脂肪性肝病(NAFLD)是具有复杂相互关系的重大全球健康问题。本研究使用生物信息学和孟德尔随机化(MR)方法研究它们共同的生物标志物和因果关系。

方法

我们分析了来自基因表达综合数据库(GEO)的NAFLD和HF数据集。GSE126848数据集包括57个肝活检样本[14名健康个体、12名肥胖受试者、15名NAFL患者和16名非酒精性脂肪性肝炎(NASH)患者]。GSE24807数据集包含12个NASH样本和5个健康对照。GSE57338数据集包括313个心肌样本[177名HF患者(95名缺血性心脏病患者和82名特发性扩张型心肌病患者)和136名健康对照]。GSE84796数据集由10名终末期HF患者和7个从器官供体获取的健康心脏组成。我们鉴定了差异表达基因(DEG)并构建了蛋白质-蛋白质相互作用(PPI)网络。通过使用基因本体论(GO)、京都基因与基因组百科全书(KEGG)和GeneMANIA注释进行富集分析来阐明功能途径。HF和NAFLD的单核苷酸多态性(SNP)数据来自全基因组关联研究(GWAS)。HF数据集包括486160个样本(14262个实验样本和471898个对照样本),NAFLD数据集包括377988个样本(4761个实验样本和373227个对照样本)。MR分析研究因果相互关系。

结果

我们的分析从GSE126848中鉴定出4032个DEG,从GSE57338中鉴定出286个DEG。前10个枢纽基因(CD163、VSIG4、CXCL10、FCER1G、FPR1、C1QB、CCR1、C1orf162、MRC1和CD38)在免疫反应、钙离子浓度调节和单核细胞趋化性的正调节中显著富集。CIBERSORT分析表明这些枢纽基因与自然杀伤(NK)细胞和巨噬细胞之间存在关联。对CD38、CXCL10和CCR1的转录因子(TF)靶标预测突出了相关的TF。两样本MR分析证实了NAFLD与HF之间的双向因果关系。主要方法[逆方差加权(IVW)]显示NAFLD与HF之间存在显著的正因果关系[P = 0.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/8277d149994d/EHF2-11-4185-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/2f783cca5934/EHF2-11-4185-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/d17a1de5a427/EHF2-11-4185-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/a70c8c6ff716/EHF2-11-4185-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/3bafe2cfce7e/EHF2-11-4185-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/1d0c932976ca/EHF2-11-4185-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/98884061eeaa/EHF2-11-4185-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/773a0f681776/EHF2-11-4185-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/ec810ac724b9/EHF2-11-4185-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/8277d149994d/EHF2-11-4185-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/2f783cca5934/EHF2-11-4185-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/d17a1de5a427/EHF2-11-4185-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/a70c8c6ff716/EHF2-11-4185-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/3bafe2cfce7e/EHF2-11-4185-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/1d0c932976ca/EHF2-11-4185-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/98884061eeaa/EHF2-11-4185-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/773a0f681776/EHF2-11-4185-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/ec810ac724b9/EHF2-11-4185-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e20/11631243/8277d149994d/EHF2-11-4185-g009.jpg

相似文献

1
Non-alcoholic fatty liver disease and heart failure: A comprehensive bioinformatics and Mendelian randomization analysis.非酒精性脂肪性肝病与心力衰竭:一项全面的生物信息学和孟德尔随机化分析
ESC Heart Fail. 2024 Dec;11(6):4185-4200. doi: 10.1002/ehf2.15019. Epub 2024 Aug 14.
2
Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and heart failure.鉴定非酒精性脂肪性肝病和心力衰竭发病机制关联的共同特征基因和途径。
Front Immunol. 2024 Sep 16;15:1424308. doi: 10.3389/fimmu.2024.1424308. eCollection 2024.
3
Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.生物信息学分析揭示了与非酒精性脂肪性肝病和非酒精性脂肪性肝炎相关的新核心基因。
Gene. 2020 Jun 5;742:144549. doi: 10.1016/j.gene.2020.144549. Epub 2020 Mar 14.
4
Exploration of the core pathway of inflammatory bowel disease complicated with metabolic fatty liver and two-sample Mendelian randomization study of the causal relationships behind the disease.炎症性肠病合并代谢性脂肪肝的核心通路探索及该疾病背后因果关系的两样本孟德尔随机化研究
Front Immunol. 2024 Apr 18;15:1375654. doi: 10.3389/fimmu.2024.1375654. eCollection 2024.
5
The role of differentially expressed genes and immune cell infiltration in the progression of nonalcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): a new exploration based on bioinformatics analysis.差异表达基因和免疫细胞浸润在非酒精性脂肪性肝炎(NASH)向肝细胞癌(HCC)进展中的作用:基于生物信息学分析的新探索
Nucleosides Nucleotides Nucleic Acids. 2024;43(12):1415-1430. doi: 10.1080/15257770.2024.2310044. Epub 2024 Feb 6.
6
Identification of biomarkers associated with coronary artery disease and non-alcoholic fatty liver disease by bioinformatics analysis and machine learning.通过生物信息学分析和机器学习识别与冠状动脉疾病和非酒精性脂肪性肝病相关的生物标志物
Sci Rep. 2025 Jan 28;15(1):3557. doi: 10.1038/s41598-025-87923-7.
7
Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study.1 型糖尿病和非酒精性脂肪性肝病:两样本孟德尔随机研究。
Front Endocrinol (Lausanne). 2024 Apr 12;15:1315046. doi: 10.3389/fendo.2024.1315046. eCollection 2024.
8
A Mendelian randomization study reveals a causal association between NASH and the risk of atrial fibrillation.一项孟德尔随机化研究揭示了非酒精性脂肪性肝炎与心房颤动风险之间的因果关联。
Front Endocrinol (Lausanne). 2025 Mar 18;16:1390259. doi: 10.3389/fendo.2025.1390259. eCollection 2025.
9
Identification of atrial fibrillation-related genes through transcriptome data analysis and Mendelian randomization.通过转录组数据分析和孟德尔随机化鉴定心房颤动相关基因。
Front Cardiovasc Med. 2024 Jul 11;11:1414974. doi: 10.3389/fcvm.2024.1414974. eCollection 2024.
10
Assessing Causal Relationships Between Periodontitis and Non-alcoholic Fatty Liver Disease: A Two-Sample Bidirectional Mendelian Randomisation Study.评估牙周炎和非酒精性脂肪性肝病之间的因果关系:两样本双向孟德尔随机研究。
Oral Health Prev Dent. 2024 May 28;22:189-202. doi: 10.3290/j.ohpd.b5395053.

引用本文的文献

1
Immunogenic cell death-related biomarkers in heart failure probed by transcriptome and single-cell sequencing.通过转录组和单细胞测序探究心力衰竭中免疫原性细胞死亡相关生物标志物
Front Immunol. 2025 Jun 24;16:1560903. doi: 10.3389/fimmu.2025.1560903. eCollection 2025.
2
Cathepsin K as a key regulator of myocardial fibrosis in dilated cardiomyopathy and a promising therapeutic target.组织蛋白酶K作为扩张型心肌病中心肌纤维化的关键调节因子及一个有前景的治疗靶点。
J Biol Chem. 2025 Jun 25;301(8):110421. doi: 10.1016/j.jbc.2025.110421.
3
APM-Related gene signature model to predict prognosis and immunotherapy response in hepatocellular carcinoma.

本文引用的文献

1
Hypoxia Induces M2 Macrophages to Express VSIG4 and Mediate Cardiac Fibrosis After Myocardial Infarction.缺氧诱导 M2 巨噬细胞表达 VSIG4 并介导心肌梗死后的心脏纤维化。
Theranostics. 2023 Apr 2;13(7):2192-2209. doi: 10.7150/thno.78736. eCollection 2023.
2
Heart failure with preserved ejection fraction and non-alcoholic fatty liver disease: new insights from bioinformatics.射血分数保留的心力衰竭与非酒精性脂肪性肝病:生物信息学的新见解。
ESC Heart Fail. 2023 Feb;10(1):416-431. doi: 10.1002/ehf2.14211. Epub 2022 Oct 20.
3
Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology.
用于预测肝细胞癌预后和免疫治疗反应的APM相关基因特征模型
Hum Genet. 2025 May 27. doi: 10.1007/s00439-025-02753-x.
4
Role of metabolic dysfunction-associated fatty liver disease in atrial fibrillation and heart failure: molecular and clinical aspects.代谢功能障碍相关脂肪性肝病在心房颤动和心力衰竭中的作用:分子与临床层面
Front Cardiovasc Med. 2025 Apr 8;12:1573841. doi: 10.3389/fcvm.2025.1573841. eCollection 2025.
5
Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction.超越体重减轻:胰高血糖素样肽-1受体激动剂治疗射血分数保留的心力衰竭的潜力
Heart Fail Rev. 2025 Jan;30(1):17-38. doi: 10.1007/s10741-024-10438-2. Epub 2024 Sep 13.
代谢相关脂肪性肝病与左心室舒张功能和心脏形态的相关性。
Front Endocrinol (Lausanne). 2022 Jul 19;13:935390. doi: 10.3389/fendo.2022.935390. eCollection 2022.
4
Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey.非酒精性脂肪性肝病、心力衰竭与长期死亡率:来自美国国家健康与营养检查调查的见解
Curr Probl Cardiol. 2022 Dec;47(12):101333. doi: 10.1016/j.cpcardiol.2022.101333. Epub 2022 Jul 25.
5
Understanding the cellular interactome of non-alcoholic fatty liver disease.了解非酒精性脂肪性肝病的细胞相互作用组。
JHEP Rep. 2022 Jun 15;4(8):100524. doi: 10.1016/j.jhepr.2022.100524. eCollection 2022 Aug.
6
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association.非酒精性脂肪性肝病与心血管风险:美国心脏协会的科学声明
Arterioscler Thromb Vasc Biol. 2022 Jun;42(6):e168-e185. doi: 10.1161/ATV.0000000000000153. Epub 2022 Apr 14.
7
Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort study.可溶性CD163与系统性红斑狼疮患者的心血管事件发生:一项观察性队列研究。
J Intern Med. 2022 Sep;292(3):536-539. doi: 10.1111/joim.13490. Epub 2022 Apr 10.
8
Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week.非酒精性脂肪性肝病患者发生心力衰竭的风险:JACC 综述专题。
J Am Coll Cardiol. 2022 Jan 18;79(2):180-191. doi: 10.1016/j.jacc.2021.11.007.
9
Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality.免疫调节受体VSIG4在自发性细菌性腹膜炎期间释放,并可预测短期死亡率。
JHEP Rep. 2021 Nov 3;4(1):100391. doi: 10.1016/j.jhepr.2021.100391. eCollection 2022 Jan.
10
Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction.非酒精性脂肪性肝病与射血分数保留的心力衰竭之间的关系
JACC Basic Transl Sci. 2021 Nov 22;6(11):918-932. doi: 10.1016/j.jacbts.2021.07.010. eCollection 2021 Nov.